Diagnosis and Pharmacotherapy of Alcohol Use Disorder: A Review

scientific article published on 01 August 2018

Diagnosis and Pharmacotherapy of Alcohol Use Disorder: A Review is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1001/JAMA.2018.11406
P698PubMed publication ID30167705

P50authorHenry R. KranzlerQ67465892
P2093author name stringMichael Soyka
P433issue8
P407language of work or nameEnglishQ1860
P921main subjectalcohol abuseQ7331102
P1104number of pages10
P304page(s)815-824
P577publication date2018-08-01
P1433published inThe Journal of the American Medical AssociationQ1470970
P1476titleDiagnosis and Pharmacotherapy of Alcohol Use Disorder: A Review
P478volume320

Reverse relations

cites work (P2860)
Q64058138Adding an orange to the banana bag: vitamin C deficiency is common in alcohol use disorders
Q90450428Advances in the science and treatment of alcohol use disorder
Q93068492Alcohol use disorders
Q93064374Allele-specific expression and high-throughput reporter assay reveal functional genetic variants associated with alcohol use disorders
Q90107347Case Study: Naltrexone for the Treatment of Nitrous Oxide Use
Q97556121Compulsive alcohol consumption is regulated by dorsal striatum fast-spiking interneurons
Q64230853Compulsivity in Alcohol Use Disorder and Obsessive Compulsive Disorder: Implications for Neuromodulation
Q90929841Educational attainment impacts drinking behaviors and risk for alcohol dependence: results from a two-sample Mendelian randomization study with ~780,000 participants
Q99709219Effects of Paternal Preconception Vapor Alcohol Exposure Paradigms on Behavioral Responses in Offspring
Q93003233Epidemiology of Alcohol Use and Alcoholic Liver Disease
Q92814833Essential Amino Acid Supplement Lowers Intrahepatic Lipid despite Excess Alcohol Consumption
Q98226106Gabapentin for Post-Hospitalization Alcohol Relapse Prevention; Should Gabapentin Be Considered for FDA Approval in the Treatment of Alcohol Use Disorder?: A Case Presentation and Literature Review
Q97540059Gabapentinoids for treatment of alcohol use disorder: A systematic review and meta-analysis
Q92169542HIV and alcohol use disorder: we cannot ignore the elephant in the room
Q92862556Mood Disorders and Severity of Addiction in Alcohol-Dependent Patients Could Be Mediated by Sex Differences
Q89905655Pharmacotherapeutic management of co-morbid alcohol and opioid use
Q64078580Predisposition to Alcohol Drinking and Alcohol Consumption Alter Expression of Calcitonin Gene-Related Peptide, Neuropeptide Y, and Microglia in Bed Nucleus of Stria Terminalis in a Subnucleus-Specific Manner
Q90828795Prevention, screening, and treatment for heavy drinking and alcohol use disorder
Q90828804Psychiatric comorbidities in alcohol use disorder
Q90737471Receptor Tyrosine Kinases as Therapeutic Targets for Alcohol Use Disorder
Q89739673Shared genetic risk between eating disorder- and substance-use-related phenotypes: Evidence from genome-wide association studies
Q89964622Survey of Addiction Specialists' Use of Medications to Treat Alcohol Use Disorder
Q92069642Understanding Addiction Using Animal Models

Search more.